Meriwether Wealth & Planning’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$449K Buy
1,066
+40
+4% +$15.9K 0.2% 73
2026
Q2
$372K Sell
1,026
-11
-1% -$3.76K 0.18% 80
2026
Q1
$365K Sell
1,037
-31
-3% -$11.1K 0.2% 76
2025
Q4
$350K Sell
1,068
-73
-6% -$23.2K 0.2% 77
2025
Q3
$322K Sell
1,141
-140
-11% -$40.6K 0.19% 82
2025
Q2
$358K Sell
1,281
-364
-22% -$103K 0.22% 75
2025
Q1
$512K Buy
1,645
+44
+3% +$13K 0.33% 57
2024
Q4
$417K Buy
+1,601
New +$475K 0.3% 63

Other funds holding AMGN

Meriwether Wealth & Planning's AMGN Position: Q3 2026 in Review

Meriwether Wealth & Planning increased its Amgen (AMGN) stake by 3.9% in Q3 2026, buying an estimated $15.9K and bringing the position to 1,066 shares worth $449K. The position accounts for 0.2% of the portfolio, ranked #73.

Meriwether Wealth & Planning first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. The position peaked at $512K in Q1 2025. 965 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Meriwether Wealth & Planning held 1,066 shares of Amgen worth $449K as of Q3 2026.
  • Meriwether Wealth & Planning bought 40 Amgen shares in Q3 2026, an estimated $15.9K.
  • Amgen made up 0.2% of Meriwether Wealth & Planning's portfolio in Q3 2026, its #73 holding.
  • Meriwether Wealth & Planning first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • Meriwether Wealth & Planning's Amgen position peaked at $512K in Q1 2025.
  • 965 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q3 2026, filed 13 Oct 2026.